Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
2020 · Clinical Cancer Research · 136 citations
https://doi.org/10.1158/1078-0432.ccr-19-3976
J
Jing Zhao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
245
Citations
7
h-index
5
i10-index
Jing Zhao is an academic researcher from Qinghai University. The author has contributed to research in topics: Protein Kinase Regulation and GTPase Signaling & Cancer-related Molecular Pathways & Ion Transport and Channel Regulation. The author has an h-index of 7, co-authored 18 publications.
ORCID: 0000-0002-0237-7122Papers by this author
worksTargeted inhibition of PTPN22 is a novel approach to alleviate osteogenic responses in aortic valve interstitial cells and aortic valve lesions in mice
2023 · BMC Medicine · 9 citations
https://doi.org/10.1186/s12916-023-02888-6
Prenatal findings in a fetus with X-linked recessive type of chondrodysplasia punctata (CDPX1): a case report with novel mutation
2019 · BMC Pediatrics · 8 citations
https://doi.org/10.1186/s12887-019-1629-x
The level of phosphorylated Akt predominantly reflects the expressive status of CerbB2 in invasive breast cancer.
2013 · PubMed · 0 citations
https://doi.org/10.14670/hh-28.655
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat